Skip to main content
. 2022 Feb 16;12:768659. doi: 10.3389/fmicb.2021.768659

TABLE 2.

Demographic, bacteriological, phenotypic resistance, and clinical characteristics of genomic clustered and non-clustered cases in Shanghai, China, 2009–2018.

Characteristics Clustered (N = 94)
Non-clustered (N = 251)
Total (N = 345)
χ2 P
N % N % N %
Sex 0.36 0.55
Male 79 84.04 204 81.27 283 82.03
Female 15 15.96 47 18.73 62 17.97
Age* (y)
15–24 15 15.96 27 10.76 42 12.17 Ref
25–34 10 10.64 24 9.56 34 9.85 0.34 0.56
35–44 7 7.45 17 6.77 24 6.96 0.29 0.59
45–54 14 14.89 28 11.16 42 12.18 0.05 0.82
55–64 23 24.47 31 12.35 54 15.65 0.47 0.49
65≥ 25 26.60 124 49.40 149 43.19 6.77 0.01
Census register 3.94 0.04
Resident 82 87.23 195 77.69 277 80.29
Migrant 12 12.77 56 22.31 68 19.71
Occupation 4.50 0.03
Student 11 11.70 13 5.18 24 6.96
Non-student 83 88.30 238 94.82 321 93.04
TB-history 1.88 0.17
Yes 17 18.09 31 12.35 48 13.91
No 77 81.91 220 87.65 297 86.09
Beijing genotype strains 5.76 0.02
Yes 88 93.62 210 83.67 298 86.38
No 6 6.38 41 16.33 47 13.62
MDR-TB 0.26
Yes 7 7.45 10 3.98 17 4.93
No 87 92.55 241 96.02 328 95.07
Resistance to INH 7.11 0.01
Yes 19 20.21 24 9.56 43 12.46
No 75 79.79 227 90.44 302 87.54
Drug resistance 6.43 0.01
Yes 22 23.40 31 12.35 53 15.36
No 72 76.60 220 87.65 292 84.64
Health system delay 6.45 0.01
<14 days 71 75.53 218 86.85 289 83.77
≥14 days 23 24.47 33 13.15 56 16.23
Source of patients** 1.95 0.38
Clinical consultation 35 37.23 98 39.8 133 39.00
Referral 58 61.70 140 56.68 198 58.06
Others 1 1.06 9 3.64 10 2.93
Complications** 0.42 0.51
Yes 7 7.45 24 9.72 31 9.09
No 87 92.55 223 90.28 310 90.91
Sputum smear** 0.56 0.45
Yes 63 67.74 174 71.9 237 70.75
No 30 32.26 68 28.1 98 29.25
Cavity** 0 0.99
Yes 33 35.11 85 35.12 118 35.12
No 61 64.89 157 64.88 218 64.88

*Univariate logistic analysis, Ref, reference.

Represents the P-value calculated by Fisher’s exact probability method.

**The clinical information of some samples was missing.

The bold values mean these factors were statistically significant.